ALNY upcoming presentations - Goldman Sachs 40th Annual Global Healthcare Conference | ALNY Message Board Posts

Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34606 of 34648  at  6/13/2019 11:25:47 AM  by

Steve_382


 In response to msg 34605 by  Steve_382
view thread

Re: ALNY upcoming presentations - Goldman Sachs 40th Annual Global Healthcare Conference

 Saw this on my news feed
 
 

10:13 AM EDT, 06/13/2019 (MT Newswires) -- Alnylam Pharmaceuticals(ALNY) said new data from a study of its ONPATTRO drug show that the treatment can stop, or even reverse, neuropathy progression in those with hereditary ATTR amyloidosis with polyneuropathy.

The company said the progression halt or reversal appears to be long-term. The treatment also seems to improve quality of life.

Alnylam said it will also report the analysis results of another ONPATTRO efficacy study.

 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 85
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34607 Re: ALNY upcoming presentations - Goldman Sachs 40th Annual Global Healthcare Conference bandrews 0 6/13/2019 9:45:30 PM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...